loading

Finanzdaten der Century Therapeutics Inc-Aktie (IPSC)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
100.00%
-
109.16 4.173 0.791 0.771
Operating Expenses
0.93%
34.66
34.99 41.46 35.58 35.53
Benefits Costs and Expenses
65.14
- 38.47 32.02 31.96
Costs And Expenses
65.14
- 38.47 32.02 31.96
Operating Income/Loss
146.73%
-34.66
74.18 -37.28 -34.79 -34.76
Nonoperating Income/Loss
10.95%
2.123
2.384 2.987 3.555 3.57
Income/Loss From Continuing Operations Before Tax
142.50%
-32.54
76.56 -34.30 -31.23 -31.18
Income/Loss From Continuing Operations After Tax
142.50%
-32.54
76.56 -36.07 -31.23 -31.21
Net Income/Loss
142.50%
-32.54
76.56 -36.07 -31.23 -31.21
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.25%
86.24
86.02 2.2547 84.70 82.09
Diluted Average Shares
0.16%
86.24
86.10 2.2547 84.70 82.09
Basic Earnings Per Share
142.70%
-0.38
0.89 -0.43 -0.37 -0.38
Diluted Earnings Per Share
142.70%
-0.38
0.89 -0.43 -0.37 -0.38
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$35.64
price up icon 0.62%
$84.80
price up icon 1.07%
$28.08
price down icon 0.57%
$98.15
price down icon 1.12%
$144.78
price up icon 0.02%
biotechnology ONC
$332.20
price up icon 1.53%
Kapitalisierung:     |  Volumen (24h):